Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: A hypothesis generating study

Radiotherapy and Oncology

Volumn 99, Issue 2, 2011, Pages 172-175

  Van Loon, Judith ^a,c   Offermann, Claudia ^a   Öllers, Michel ^a   Van Elmpt, Wouter ^a   Vegt, Erik ^a   Rahmy, Ali ^b   Dingemans, Anne Marie C ^a   Lambin, Philippe ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c MAASTRO CLINIC   (Netherlands)

Author keywords

Metabolic response; Outcome prediction; PET; SCLC; Small cell lung cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HUMAN; LUNG SMALL CELL CANCER; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; TREATMENT DURATION; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRONCHOSCOPY; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79958178781     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.03.014     Document Type: Article

References (34)

1. M. Pelayo Alvarez, O. Gallego Rubio, X. Bonfill Cosp, and Y. Agra Varela Chemotherapy versus best supportive care for extensive small cell lung cancer Cochrane Database Syst Rev 2009 CD001990
2. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1992 1618 1624
3. P. Warde, and D. Payne Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis J Clin Oncol 10 1992 890 895
4. D. de Ruysscher Treatment of limited disease small cell lung cancer Front Radiat Ther Oncol 42 2010 173 179
5. A. Paumier, and C. Le Pechoux Radiotherapy in small-cell lung cancer: where should it go? Lung Cancer 69 2010 133 140
6. M. Baumann, D. Zips, and S. Appold Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity Radiother Oncol 91 2009 279 281
7. D.B. Fried, D.E. Morris, and C. Poole Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer J Clin Oncol 22 2004 4837 4845
8. M. Pijls-Johannesma, D. De Ruysscher, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials Cancer Treat Rev 33 2007 461 473 (Pubitemid 47324226)
9. M.C. Pijls-Johannesma, D. De Ruysscher, P. Lambin, I. Rutten, and J.F. Vansteenkiste Early versus late chest radiotherapy for limited stage small cell lung cancer Cochrane Database Syst Rev 2005 CD004700
10. A.T. Turrisi III, K. Kim, and R. Blum Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 271 (Pubitemid 29063268)
11. F.A. Shepherd, J. Crowley, and P. Van Houtte The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer J Thorac Oncol 2 2007 1067 1077 (Pubitemid 350307898)
12. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
13. R.P. Baum, D. Hellwig, and M. Mezzetti Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer Q J Nucl Med Mol Imaging 48 2004 119 142 (Pubitemid 39248300)
14. J.F. Bruzzi, and R.F. Munden PET/CT imaging of lung cancer J Thorac Imaging 21 2006 123 136 (Pubitemid 43904260)
15. E.M. Toloza, L. Harpole, and D.C. McCrory Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 2003 137S 146S (Pubitemid 36135711)
16. A. van Baardwijk, B.G. Baumert, and G. Bosmans The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat Rev 32 2006 245 260 (Pubitemid 44502002)
17. B.M. Fischer, J. Mortensen, and S.W. Langer A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis Ann Oncol 18 2007 338 345 (Pubitemid 46323103)
18. S. Niho, H. Fujii, and K. Murakami Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer Lung Cancer 57 2007 328 333 (Pubitemid 47285426)
19. 18F]FDG-PET on the primary staging of small-cell lung cancer Eur J Nucl Med Mol Imaging 31 2004 1614 1620 (Pubitemid 40104607)
20. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review J Natl Cancer Inst 99 2007 1753 1767 (Pubitemid 351767209)
21. C. Gillham, D. Zips, and F. Ponisch Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol 88 2008 335 341
22. A. van Baardwijk, G. Bosmans, and A. Dekker Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients Radiother Oncol 82 2007 145 152
23. 18F-FDG PET in colorectal cancer: a systematic review J Nucl Med 50 2009 43S 54S
24. M. Schelling, N. Avril, and J. Nahrig Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 2000 1689 1695 (Pubitemid 30220547)
25. H.A. Wieder, B.L. Brucher, and F. Zimmermann Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908 (Pubitemid 41103602)
26. 18F]-2-fluoro-2-deoxy-d-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer J Clin Oncol 23 2005 8362 8370
27. 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer J Thorac Oncol 4 2009 816 821
28. W.A. Weber, V. Petersen, and B. Schmidt Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use J Clin Oncol 21 2003 2651 2657 (Pubitemid 46606307)
29. A.F. Shields, D.A. Mankoff, and J.M. Link Carbon-11-thymidine and FDG to measure therapy response J Nucl Med 39 1998 1757 1762 (Pubitemid 28473526)
30. Y. Yamamoto, R. Kameyama, M. Murota, S. Bandoh, T. Ishii, and Y. Nishiyama Early assessment of therapeutic response using FDG PET in small cell lung cancer Mol Imaging Biol 11 2009 467 472
31. B.M. Fischer, J. Mortensen, and S.W. Langer PET/CT imaging in response evaluation of patients with small cell lung cancer Lung Cancer 54 2006 41 49
32. P. Vera, P. Bohn, and A. Edet-Sanson Simultaneous positron emission tomography (PET) assessment of metabolism with (1)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (1)F-fluoro-thymidine (FLT), and hypoxia with (1)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2011 109 116
33. D. De Ruysscher, M. Pijls-Johannesma, and S.M. Bentzen Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer J Clin Oncol 24 2006 1057 1063 (Pubitemid 46638802)
34. D. De Ruysscher, M. Pijls-Johannesma, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer Ann Oncol 17 2006 543 552